PerkinElmer introduces two multiplexing platforms
research, which provides important tools for improving gene
expression validation, molecular karyotyping and genome profiling.
Within the Comprehensive Solution (CS) Autoplex Platform, PerkinElmer is launching two products for gene expression validation - a custom gene expression panel kit and a labelling kit, both with analysis software.
The CS Autoplex Custom Gene Expression Panel Kit enables researchers to customise their candidate gene panels for the high throughput validation of large sample sets.
Validation of genomic biomarkers is a critical area of research for drug discovery and potential disease diagnostics.
These kits, built upon Luminex's xMAP technology, are designed to reduce the cost of sample processing, while facilitating the progress of microarray-based discovery by efficiently validating biomarkers with reproducible results.
CS Autoplex Analysis Software offers a familiar output format for standard ratiometric microarray data analysis and visualisation.
With the Spectral Genomics Array CGH Platform, PerkinElmer offers a Bacterial Artificial Chromosome (BAC) based integrated solution consisting of the SpectralChip 2600 array, the Constitutional Chip 3.0 array, the ScanArray System, labelling reagents and SpectralWare Analysis Software, which reduces research time.
Researchers can use the platform for discovery and investigational purposes. This PerkinElmer solution can generate results in 24 hours versus the industry standard of five to 20 days in the lab, which is common for standard karyotyping.
"With the acquisition of Spectral Genomics and our partnership with Luminex Corporation to use xMAP technology, PerkinElmer is strengthening its commitment to the genomics market," said Robert Friel, president of PerkinElmer Life and Analytical Sciences.
"We now offer solutions that accelerate the discovery and validation of genomic profiles and applications."
